EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388–402. https://doi.org/10.1016/j.jhep.2015.11.004

Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–31. https://doi.org/10.1056/NEJMra011775.

Article  CAS  PubMed  Google Scholar 

Li J, Zou B, Yeo YH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4:389–98. https://doi.org/10.1016/s2468-1253(19)30039-1.

Article  PubMed  Google Scholar 

Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002;122:1649–57. https://doi.org/10.1053/gast.2002.33573.

Article  PubMed  Google Scholar 

Kimura T, Tanaka N, Fujimori N, et al. Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis. World J Gastroenterol. 2018;24:1440–50. https://doi.org/10.3748/wjg.v24.i13.1440.

Article  PubMed  PubMed Central  Google Scholar 

Tanaka N, Kimura T, Fujimori N, et al. Current status, problems, and perspectives of non-alcoholic fatty liver disease research. World J Gastroenterol. 2019;25:163–77. https://doi.org/10.3748/wjg.v25.i2.163.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gutierrez-Grobe Y, Ponciano-Rodríguez G, Ramos MH, et al. Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens. Ann Hepatol. 2010;9:402–9.

Article  PubMed  Google Scholar 

Yang JD, Abdelmalek MF, Pang H, et al. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology. 2014;59:1406–14. https://doi.org/10.1002/hep.26761.

Article  CAS  PubMed  Google Scholar 

DiStefano JK. NAFLD and NASH in postmenopausal women: implications for diagnosis and treatment. Endocrinology. 2020. https://doi.org/10.1210/endocr/bqaa134.

Article  PubMed  PubMed Central  Google Scholar 

Brady CW. Liver disease in menopause. World J Gastroenterol. 2015;21:7613–20. https://doi.org/10.3748/wjg.v21.i25.7613.

Article  PubMed  PubMed Central  Google Scholar 

Kimura T, Singh S, Tanaka N, et al. Role of G protein-coupled receptors in hepatic stellate cells and approaches to anti-fibrotic treatment of non-alcoholic fatty liver disease. Front Endocrinol (Lausanne). 2021;12: 773432. https://doi.org/10.3389/fendo.2021.773432.

Article  PubMed  Google Scholar 

Lizcano F, Guzmán G. Estrogen deficiency and the origin of obesity during menopause. Biomed Res Int. 2014;2014: 757461. https://doi.org/10.1155/2014/757461.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pillai OC, Manyonda I. The surgical menopause. Best Pract Res Clin Obstet Gynaecol. 2022;81:111–8. https://doi.org/10.1016/j.bpobgyn.2022.03.001.

Article  Google Scholar 

Nagaya T, Tanaka N, Suzuki T, et al. Down-regulation of SREBP-1c is associated with the development of burned-out NASH. J Hepatol. 2010;53:724–31. https://doi.org/10.1016/j.jhep.2010.04.033.

Article  CAS  PubMed  Google Scholar 

Cooke PS, Naaz A. Role of estrogens in adipocyte development and function. Exp Biol Med (Maywood). 2004;229:1127–35. https://doi.org/10.1177/153537020422901107.

Article  CAS  PubMed  Google Scholar 

Stubbins RE, Najjar K, Holcomb VB, et al. Oestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance. Diabetes Obes Metab. 2012;14:58–66. https://doi.org/10.1111/j.1463-1326.2011.01488.x.

Article  CAS  PubMed  Google Scholar 

Carulli L, Lonardo A, Lombardini S, et al. Gender, fatty liver and GGT. Hepatology. 2006;44:278–9. https://doi.org/10.1002/hep.21218.

Article  PubMed  Google Scholar 

Nemoto Y, Toda K, Ono M, et al. Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J Clin Invest. 2000;105:1819–25. https://doi.org/10.1172/jci9575.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yasuda M, Shimizu I, Shiba M, et al. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology. 1999;29:719–27. https://doi.org/10.1002/hep.510290307.

Article  CAS  PubMed  Google Scholar 

Shimizu I, Mizobuchi Y, Yasuda M, et al. Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro. Gut. 1999;44:127–36. https://doi.org/10.1136/gut.44.1.127.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Itagaki T, Shimizu I, Cheng X, et al. Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells. Gut. 2005;54:1782–9. https://doi.org/10.1136/gut.2005.053278.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yoneda M, Thomas E, Sumida Y, et al. The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease. Hepatology. 2014;60:1792. https://doi.org/10.1002/hep.27097.

Article  PubMed  Google Scholar 

Kawanaka M, Nishino K, Morimoto Y, et al. Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis cirrhosis confirmed by liver histology after 14 Years. Intern Med. 2021;60:1397–401. https://doi.org/10.2169/internalmedicine.6118-20.

Article  PubMed  Google Scholar 

Wright JD. Take ’em or leave ’em: management of the ovaries in young women with endometrial cancer. Gynecol Oncol. 2013;131:287–8. https://doi.org/10.1016/j.ygyno.2013.09.026.

Article  PubMed  Google Scholar 

Matsuo K, Gualtieri MR, Cahoon SS, et al. Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer. Menopause. 2016;23:189–96. https://doi.org/10.1097/gme.0000000000000500.

Article  PubMed  PubMed Central  Google Scholar 

Klair JS, Yang JD, Abdelmalek MF, et al. A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. Hepatology. 2016;64:85–91. https://doi.org/10.1002/hep.28514.

Article  CAS  PubMed  Google Scholar 

McKenzie J, Fisher BM, Jaap AJ, et al. Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. Clin Endocrinol (Oxf). 2006;65:40–4. https://doi.org/10.1111/j.1365-2265.2006.02543.x.

Article  CAS  PubMed  Google Scholar 

Pearce J, Hawton K, Blake F. Psychological and sexual symptoms associated with the menopause and the effects of hormone replacement therapy. Br J Psychiatry. 1995;167:163–73. https://doi.org/10.1192/bjp.167.2.163.

Article  CAS  PubMed  Google Scholar 

Langenberg P, Kjerulff KH, Stolley PD. Hormone replacement and menopausal symptoms following hysterectomy. Am J Epidemiol. 1997;146:870–80. https://doi.org/10.1093/oxfordjournals.aje.a009204.

Article  CAS  PubMed  Google Scholar 

Keating NL, Cleary PD, Rossi AS, et al. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med. 1999;130:545–53. https://doi.org/10.7326/0003-4819-130-7-199904060-00002.

Article  CAS  PubMed